Pharmaceutical company Inovio plans to begin a Phase 2/3 clinical trial of its COVID-19 vaccine candidate this month, according to company president and CEO Dr. Joseph Kim
The pharmaceutical company Inovio plans to begin a Phase 2/3 clinical trial of its COVID-19 vaccine candidate this month, according to company president and CEO Dr. Joseph Kim.
Inovio's vaccine technology works by delivering particles of DNA directly into cells, triggering an immune response to the novel coronavirus inside the cells.Inovio plans to enroll 6,000 to 10,000 volunteers in the study. That’s less than the 30,000 volunteers who are being enrolled in clinical trials for several other COVID-19 vaccine candidates.
In August, Inovio shared results of small a Phase 1 clinical trial involving 40 volunteers. Side effects were mild, and the vaccine showed evidence of neutralizing antibodies and T cell responses.Inovio’s COVID-19 vaccine is being funded, in part, by the US Department of Defense, the Bill & Melinda Gates Foundation, and The Coalition for Epidemic Preparedness Innovations.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer and BioNTech approved to start phase 2/3 trial of COVID-19 vaccineGerman regulatory authority Paul-Ehrlich-Institut has approved a phase 2/3 clinical trial in Germany of a COVID-19 vaccine candidate being developed by US pharmaceutical company Pfizer and German biotechnology company BioNTech
Read more »
DOH: Pfizer will not conduct clinical trials for COVID-19 vaccine in PHUS-based drug manufacturer Pfizer will not hold clinical trials for its COVID-19 vaccine in the Philippines as it is “well advanced already” with its Phase 3 clinical trial, the DOH said. | DYGalvezINQ
Read more »
Pfizer and BioNTech approved to start phase 2/3 trial of COVID-19 vaccineGerman regulatory authority Paul-Ehrlich-Institut has approved a phase 2/3 clinical trial in Germany of a COVID-19 vaccine candidate being developed by US pharmaceutical company Pfizer and German biotechnology company BioNTech
Read more »
KILALANIN: Pinoy na nag-volunteer sa COVID-19 vaccine trial ng UAE
Read more »
How will the Philippines run COVID-19 vaccine trials?
Read more »
Galvez: ‘No home quarantine’ policy may lower number of new COVID casesNTF on COVID-19 chief implementer Carlito Galvez Jr. raised the possibility of bringing down new COVID-19 cases to single-digit level if a “no home quarantine” policy for coronavirus patients will be implemented. | kaguilarINQ
Read more »